Jay Barth, Chief Medical Officer

FOLD 163,204 shares

The estimated Net Worth of Jay Barth is at least $2,367,388.26. Jay Barth owns over 163,204 units of Amicus Therapeutics, Inc. stock worth over $2,367,388.26.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th September 2020FOLD - Amicus Therapeutics, Inc.4,064Open or private sale163,204$14.51$58,951.16$2,367,388.26
30th September 2020FOLD - Amicus Therapeutics, Inc.4,064Exercise of derivative167,268$2.29$9,306.56$383,043.72
3rd January 2019FOLD - Amicus Therapeutics, Inc.9,521Payment by withholding129,767$10.33$98,351.93$1,340,493.11
2nd January 2019FOLD - Amicus Therapeutics, Inc.53,879Grant/award etc.139,288$0.00
25th January 2019FOLD - Amicus Therapeutics, Inc.94Sale back to the issuer31$0.00
25th February 2019FOLD - Amicus Therapeutics, Inc.43,730Open or private sale129,767$12.52$547,333.43$1,624,189.73
25th February 2019FOLD - Amicus Therapeutics, Inc.43,730Exercise of derivative173,497$2.94$128,566.20$510,081.18
25th February 2019FOLD - Amicus Therapeutics, Inc.26,270Open or private sale129,767$12.52$328,800.57$1,624,189.73
25th February 2019FOLD - Amicus Therapeutics, Inc.26,270Exercise of derivative156,037$2.29$60,158.30$357,324.73
5th April 2019FOLD - Amicus Therapeutics, Inc.50,000Open or private sale129,767$14.20$710,195.00$1,843,197.49
5th April 2019FOLD - Amicus Therapeutics, Inc.50,000Exercise of derivative179,767$2.29$114,500.00$411,666.43
11th April 2019FOLD - Amicus Therapeutics, Inc.20,579Grant/award etc.150,346$0.00
17th June 2019FOLD - Amicus Therapeutics, Inc.1,846Payment by withholding148,500$11.35$20,952.10$1,685,475.00
2nd January 2020FOLD - Amicus Therapeutics, Inc.9,753Open or private sale189,522$9.55$93,173.33$1,810,560.52
2nd January 2020FOLD - Amicus Therapeutics, Inc.61,601Grant/award etc.199,275$0.00
31st December 2019FOLD - Amicus Therapeutics, Inc.10,826Payment by withholding137,674$9.74$105,445.24$1,340,944.76
3rd January 2020FOLD - Amicus Therapeutics, Inc.9,642Payment by withholding173,247$9.18$88,513.56$1,590,407.46
2nd January 2020FOLD - Amicus Therapeutics, Inc.6,633Payment by withholding182,889$9.55$63,345.15$1,746,589.95
7th January 2020FOLD - Amicus Therapeutics, Inc.9,938Open or private sale156,473$9.36$92,979.93$1,463,961.39
6th January 2020FOLD - Amicus Therapeutics, Inc.6,836Open or private sale166,411$9.28$63,414.84$1,543,728.28
10th January 2020FOLD - Amicus Therapeutics, Inc.20,108Payment by withholding177,193$9.46$190,221.68$1,676,245.78
10th January 2020FOLD - Amicus Therapeutics, Inc.40,828Grant/award etc.197,301$0.00
15th January 2020FOLD - Amicus Therapeutics, Inc.20,720Open or private sale156,473$10.35$214,358.76$1,618,791.42
1st April 2020FOLD - Amicus Therapeutics, Inc.10,481Grant/award etc.166,954$0.00
17th June 2020FOLD - Amicus Therapeutics, Inc.1,904Open or private sale163,204$13.47$25,639.45$2,197,721.38
15th June 2020FOLD - Amicus Therapeutics, Inc.1,846Payment by withholding165,108$11.14$20,564.44$1,839,303.12
29th June 2020FOLD - Amicus Therapeutics, Inc.30,000Open or private sale163,204$15.51$465,195.00$2,530,722.83
29th June 2020FOLD - Amicus Therapeutics, Inc.30,000Exercise of derivative193,204$5.13$153,900.00$991,136.52
8th July 2020FOLD - Amicus Therapeutics, Inc.64,110Open or private sale163,204$15.92$1,020,573.50$2,598,060.80
8th July 2020FOLD - Amicus Therapeutics, Inc.22,052Exercise of derivative227,314$12.28$270,798.56$2,791,415.92
8th July 2020FOLD - Amicus Therapeutics, Inc.8,599Exercise of derivative205,262$10.04$86,333.96$2,060,830.48
8th July 2020FOLD - Amicus Therapeutics, Inc.16,549Exercise of derivative196,663$9.03$149,437.47$1,775,866.89
8th July 2020FOLD - Amicus Therapeutics, Inc.16,910Exercise of derivative180,114$8.61$145,595.10$1,550,781.54
7th July 2020FOLD - Amicus Therapeutics, Inc.178,988Open or private sale163,204$15.90$2,845,945.00$2,594,976.24
7th July 2020FOLD - Amicus Therapeutics, Inc.50,052Exercise of derivative342,192$12.28$614,638.56$4,202,117.76
7th July 2020FOLD - Amicus Therapeutics, Inc.12,804Exercise of derivative292,140$10.04$128,552.16$2,933,085.60
7th July 2020FOLD - Amicus Therapeutics, Inc.64,601Exercise of derivative279,336$9.03$583,347.03$2,522,404.08
7th July 2020FOLD - Amicus Therapeutics, Inc.51,531Exercise of derivative214,735$8.61$443,681.91$1,848,868.35
10th July 2020FOLD - Amicus Therapeutics, Inc.28,843Open or private sale163,204$15.65$451,433.33$2,554,371.09
10th July 2020FOLD - Amicus Therapeutics, Inc.28,843Exercise of derivative192,047$5.13$147,964.59$985,201.11
9th July 2020FOLD - Amicus Therapeutics, Inc.44,447Open or private sale163,204$15.92$707,494.01$2,597,832.31
9th July 2020FOLD - Amicus Therapeutics, Inc.17,896Exercise of derivative207,651$12.28$219,762.88$2,549,954.28
9th July 2020FOLD - Amicus Therapeutics, Inc.6,142Exercise of derivative189,755$10.04$61,665.68$1,905,140.20
9th July 2020FOLD - Amicus Therapeutics, Inc.8,850Exercise of derivative183,613$9.03$79,915.50$1,658,025.39
9th July 2020FOLD - Amicus Therapeutics, Inc.11,559Exercise of derivative174,763$8.61$99,522.99$1,504,709.43
27th July 2020FOLD - Amicus Therapeutics, Inc.30,000Open or private sale163,204$15.05$451,377.00$2,455,551.06
27th July 2020FOLD - Amicus Therapeutics, Inc.30,000Exercise of derivative193,204$6.10$183,000.00$1,178,544.40
31st August 2020FOLD - Amicus Therapeutics, Inc.28,750Open or private sale163,204$14.74$423,746.25$2,405,463.76
31st August 2020FOLD - Amicus Therapeutics, Inc.28,750Exercise of derivative191,954$6.10$175,375.00$1,170,919.40